Literature DB >> 28845434

Phytotherapy and Nutritional Supplements on Breast Cancer.

C M Lopes1, A Dourado2, R Oliveira1.   

Abstract

Breast cancer is the most frequent type of nonskin malignancy among women worldwide. In general, conventional cancer treatment options (i.e., surgery, radiotherapy, chemotherapy, biological therapy, and hormone therapy) are not completely effective. Recurrence and other pathologic situations are still an issue in breast cancer patients due to side effects, toxicity of drugs in normal cells, and aggressive behaviour of the tumours. From this point of view, breast cancer therapy and adjuvant methods represent a promising and challenging field for researchers. In the last few years, the use of some types of complementary medicines by women with a history of breast cancer has significantly increased such as phytotherapeutic products and nutritional supplements. Despite this, the use of such approaches in oncologic processes may be problematic and patient's health risks can arise such as interference with the efficacy of standard cancer treatment. The present review gives an overview of the most usual phytotherapeutic products and nutritional supplements with application in breast cancer patients as adjuvant approach. Regardless of the contradictory results of scientific evidence, we demonstrated the need to perform additional investigation, mainly well-designed clinical trials in order to establish correlations and allow for further validated outcomes concerning the efficacy, safety, and clinical evidence-based recommendation of these products.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28845434      PMCID: PMC5563402          DOI: 10.1155/2017/7207983

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  407 in total

Review 1.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients.

Authors:  Chun-Kwok Wong; Yi-Xi Bao; Eliza Lai-Yi Wong; Ping-Chung Leung; Kwok Pui Fung; Christopher Wai Kei Lam
Journal:  Am J Chin Med       Date:  2005       Impact factor: 4.667

3.  Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer.

Authors:  Hoda B Mabrok; Robert Klopfleisch; Kadry Z Ghanem; Thomas Clavel; Michael Blaut; Gunnar Loh
Journal:  Carcinogenesis       Date:  2011-11-10       Impact factor: 4.944

4.  Uncaria tomentosa extract increases the number of myeloid progenitor cells in the bone marrow of mice infected with Listeria monocytogenes.

Authors:  Samara Eberlin; Leonilda M B dos Santos; Mary L S Queiroz
Journal:  Int Immunopharmacol       Date:  2005-04-01       Impact factor: 4.932

5.  Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.

Authors:  Dana Seidlova-Wuttke; Oda Hesse; Hubertus Jarry; Volker Christoffel; Barbara Spengler; Tamara Becker; Wolfgang Wuttke
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

Review 6.  Antioxidants and prevention of chronic disease.

Authors:  Joye K Willcox; Sarah L Ash; George L Catignani
Journal:  Crit Rev Food Sci Nutr       Date:  2004       Impact factor: 11.176

7.  Ascorbic acid inhibits antitumor activity of bortezomib in vivo.

Authors:  G Perrone; T Hideshima; H Ikeda; Y Okawa; E Calabrese; G Gorgun; L Santo; D Cirstea; N Raje; D Chauhan; M Baccarani; M Cavo; K C Anderson
Journal:  Leukemia       Date:  2009-04-16       Impact factor: 11.528

8.  Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Authors:  Peifen Fu; Feiya Du; Wei Chen; Minya Yao; Kezhen Lv; Yu Liu
Journal:  Oncol Rep       Date:  2014-04-16       Impact factor: 3.906

9.  Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets.

Authors:  Bo-Min Kim; Do-Hee Kim; Jeong-Hill Park; Young-Joon Surh; Hye-Kyung Na
Journal:  J Cancer Prev       Date:  2014-03

10.  Are herbal remedies and dietary supplements safe and effective for breast cancer patients?

Authors:  Aedin Cassidy
Journal:  Breast Cancer Res       Date:  2003-10-07       Impact factor: 6.466

View more
  13 in total

1.  siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells.

Authors:  Supusson Pengnam; Purin Charoensuksai; Boon-Ek Yingyongnarongkul; Rungnapha Saeeng; Hasan Uludağ; Prasopchai Patrojanasophon; Praneet Opanasopit; Samarwadee Plianwong
Journal:  Pharmaceutics       Date:  2022-06-03       Impact factor: 6.525

2.  Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models.

Authors:  Po-Han Lin; Yi-Fen Chiang; Tzong-Ming Shieh; Hsin-Yuan Chen; Chun-Kuang Shih; Tong-Hong Wang; Kai-Lee Wang; Tsui-Chin Huang; Yong-Han Hong; Sing-Chung Li; Shih-Min Hsia
Journal:  Antioxidants (Basel)       Date:  2020-03-10

3.  Complementary and Alternative Medicine in Patients With Breast Cancer: Exploratory Study of Social Network Forum Data.

Authors:  Béatrice Lognos; François Carbonnel; Isabelle Boulze Launay; Sandra Bringay; Estelle Guerdoux-Ninot; Caroline Mollevi; Pierre Senesse; Gregory Ninot
Journal:  JMIR Cancer       Date:  2019-11-27

4.  Precision Nutrition and Cancer Relapse Prevention: A Systematic Literature Review.

Authors:  Clara Reglero; Guillermo Reglero
Journal:  Nutrients       Date:  2019-11-16       Impact factor: 5.717

Review 5.  Effects of therapeutic probiotics on modulation of microRNAs.

Authors:  Amirhossein Davoodvandi; Havva Marzban; Pouya Goleij; Amirhossein Sahebkar; Korosh Morshedi; Samaneh Rezaei; Maryam Mahjoubin-Tehran; Hossein Tarrahimofrad; Michael R Hamblin; Hamed Mirzaei
Journal:  Cell Commun Signal       Date:  2021-01-11       Impact factor: 5.712

6.  Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro.

Authors:  Anna-Lena Klauser; Marc Hirschfeld; Andrea Ritter; Gerta Rücker; Markus Jäger; Julia Gundarova; Daniela Weiss; Ingolf Juhasz-Böss; Kai Berner; Thalia Erbes; Jasmin Asberger
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-12-08

7.  Inhibitory effects of probiotic Bacillus coagulans against MCF7 breast cancer cells.

Authors:  Masoumeh Dolati; Farzaneh Tafvizi; Masoud Salehipour; Tahereh Komeili Movahed; Parvaneh Jafari
Journal:  Iran J Microbiol       Date:  2021-12

Review 8.  Updates in Anthracycline-Mediated Cardiotoxicity.

Authors:  Canan G Nebigil; Laurent Désaubry
Journal:  Front Pharmacol       Date:  2018-11-12       Impact factor: 5.810

9.  The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Authors:  Nazanin Zahrooni; Seyed Ahmad Hosseini; Ahmad Ahmadzadeh; Kambiz Ahmadi Angali; Mohammad Ali Assarehzadegan
Journal:  Ther Clin Risk Manag       Date:  2019-12-04       Impact factor: 2.423

Review 10.  Sulforaphane: Expected to Become a Novel Antitumor Compound.

Authors:  Geting Wu; Yuanliang Yan; Yangying Zhou; Yumei Duan; Shuangshuang Zeng; Xiang Wang; Wei Lin; Chunlin Ou; Jianhua Zhou; Zhijie Xu
Journal:  Oncol Res       Date:  2020-02-28       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.